EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Safety and efficacy of remote ischemic conditioning for spontaneous intracerebral hemorrhage (SERIC-ICH): A multicenter, randomized, parallel-controlled clinical trial study design and protocol

Zhen-Ni Guo, Yang Qu, Reziya Abuduxukuer, Peng Zhang iD, Lijuan Wang, Ying Liu, Rui-Hong Teng, Jian-Hua Gao, Feng Jin, Hai-Feng Wang, Yu Cao, Yong-Quan Xue und 4 weitere

European Stroke Journal · 01.03.2024 · 9 (1) · 259-264

DOI: 10.1177/23969873231201712 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift European Stroke Journal, online erschienen am 01.03.2024. Verfasst von Zhen-Ni Guo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, China. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Research Design. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Graduate Innovation Fund of Jilin University, Norman Bethune Program of Jilin University, Norman Bethune Health Science Center of Jilin University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies have revealed that remote ischemic conditioning (RIC) may have a neuroprotective function. However, the potential benefit of RIC for patients with ICH remain unclear.

Objective

The primary aim of this study is to assess the safety and efficacy of RIC for patients with ICH.

Methods

The Safety and Efficacy of RIC for Spontaneous ICH (SERIC-ICH) is an ongoing prospective, randomized, multicenter, parallel-controlled, and blinded-endpoint clinical trial. The study will enroll an estimated 2000 patients aged ⩾18 years within 24 h after ICH onset, with National Institutes of Health Stroke Scale ⩾6 and Glasgow Coma Scale ⩾8 upon presentation. The patients will be randomly assigned to the RIC or control groups (1:1) and will be treated with cuffs inflated to a pressure of 200 or 60 mmHg, respectively, twice daily for 7 days. Each RIC treatment will consist of four cycles of arm ischemia for 5 min, followed by reperfusion for another 5 min, for a total procedure time of 35 min. The primary efficacy outcome measure is the proportion of patients with good functional outcomes (modified Rankin scale 0–2) at 180 days. The safety outcome measures will include all adverse events and severe adverse events occurring in the course of the study.

Discussion

RIC is an inexpensive intervention and might be a strategy to improve outcomes in patients with ICH. The SERIC-ICH trial will investigate whether RIC treatment can be applied as an adjuvant treatment in the acute phase of ICH and identify safety issues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral HemorrhageResearch DesignUnited StatesHumansAgedProspective StudiesIschemiaOutcome Assessment, Health CareRandomized Controlled Trials as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

Remote ischemic conditioningclinical trialintracerebral hemorrhageprotocol

Autor:innen und Institutionen

  • Stroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, China.
  • Neuroscience Research Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, China.
  • Department of Neurology, Songyuan Central Hospital, Songyuan, China.
  • Department of Neurology, Tonghua Liuhe Hospital, Tonghua, China.
  • Department of Neurology, Dongliao First People's Hospital, Liaoyuan, China.
  • Department of Neurology, Jilin Neuropsychiatric Hospital, Siping, China.

ORCID-Profile: Peng Zhang, Thanh N Nguyen, Yi Yang

Förderung

  • Graduate Innovation Fund of Jilin University
  • Norman Bethune Program of Jilin University
  • Norman Bethune Health Science Center of Jilin University
  • Jilin Provincial Key Laboratory
  • Science and Technology Department of Jilin Province
  • National Natural Science Foundation of China

Zitieren

APA

Guo, Z. N., Qu, Y., Abuduxukuer, R., Zhang, P., Wang, L., Liu, Y., Teng, R. H., Gao, J. H., Jin, F., Wang, H. F., Cao, Y., Xue, Y. Q., Zhao, J. F., Selim, M. H., Nguyen, T. N., & Yang, Y. (2024). Safety and efficacy of remote ischemic conditioning for spontaneous intracerebral hemorrhage (SERIC-ICH): A multicenter, randomized, parallel-controlled clinical trial study design and protocol. European Stroke Journal, 9(1), 259-264. https://doi.org/10.1177/23969873231201712

Vancouver

Guo ZN, Qu Y, Abuduxukuer R, Zhang P, Wang L, Liu Y, et al. Safety and efficacy of remote ischemic conditioning for spontaneous intracerebral hemorrhage (SERIC-ICH): A multicenter, randomized, parallel-controlled clinical trial study design and protocol. European Stroke Journal. 2024;9(1):259-264. doi:10.1177/23969873231201712

BibTeX
@article{Guo2024,
  author = {Guo, Zhen-Ni and Qu, Yang and Abuduxukuer, Reziya and Zhang, Peng and Wang, Lijuan and Liu, Ying and Teng, Rui-Hong and Gao, Jian-Hua and Jin, Feng and Wang, Hai-Feng and Cao, Yu and Xue, Yong-Quan and Zhao, Jun-Feng and Selim, Magdy H and Nguyen, Thanh N and Yang, Yi},
  title = {Safety and efficacy of remote ischemic conditioning for spontaneous intracerebral hemorrhage (SERIC-ICH): A multicenter, randomized, parallel-controlled clinical trial study design and protocol},
  journal = {European Stroke Journal},
  year = {2024},
  volume = {9},
  number = {1},
  pages = {259--264},
  doi = {10.1177/23969873231201712}
}
Kostenlos starten →